Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-27T02:34:47.050Z Has data issue: false hasContentIssue false
  • English
  • Français

Utilizing Platelets as a Targeted for Gene Therapy of Hemophilia a and Hemophilia B

Published online by Cambridge University Press:  30 July 2020

Qizhen Shi
Qizhen Shi*
Affiliation:
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Biomedical and Pharmaceutical Research on the Development, Diagnosis, Prevention, and Treatment of Diseases
Information
Microscopy and Microanalysis , Volume 26 , Supplement S2 , August 2020 , pp. 826 - 827
Check for updates
Copyright
Copyright © Microscopy Society of America 2020

References

Shi, Q, Wilcox, DA, Fahs, SA, Weiler, H, Well, CC, Cooley, BC, Desai, D, Morateck, PA, Gorski, J, and Montgomery, RR. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. J Clin Invest 2006, 116 (7):1974-1982.10.1172/JCI28416CrossRefGoogle ScholarPubMed
Shi, Q, Fahs, SA, Wilcox, DA, Kuether, EL, Morateck, PA, Mareno, N, Weiler, H, and Montgomery, RR. Syngeneic transplantation of hematopoietic stem cells (HSC) that are genetically modified to express factor VIII (FVIII) in platelets restores hemostasis to hemophilia A mice with pre-existing FVIII immunity. Blood 2008,112 (7):2713-2721.10.1182/blood-2008-02-138214CrossRefGoogle Scholar
Zhang, G, Shi, Q, Fahs, SA, Kuether, EL, Walsh, CE, Montgomery, RR. Factor IX ectopically expressed in platelets can be stored in α-granules and corrects the phenotype of hemophilia B mice. Blood 2010, 116(8):1235-43. PMCID: PMC2938234.10.1182/blood-2009-11-255612CrossRefGoogle ScholarPubMed
Kuether, EL, Fahs, SA, Cooley, BC, Schroeder, JA, Chen, Y, Montgomery, RR, Wilcox, DA, and Shi, Q. Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-FVIII immunity. J Thromb Haemost. 2012 Aug;10(8):1570-80.10.1111/j.1538-7836.2012.04791.xCrossRefGoogle Scholar
Chen, Y, Schroeder, JA, Kuether, EL, Zhang, G, and Shi, Q. Lentivirus-mediated platelet gene therapy corrects bleeding diathesis and induces humoral immune tolerance in hemophilia B mice. Mol Ther. 2014; 22(1):169-77.10.1038/mt.2013.197CrossRefGoogle Scholar
Shi, Q, Kuether, EL, Chen, Y, Schroeder, JA, Fahs, SA, and Montgomery, RR. Platelet gene therapy corrects the hemophilic phenotype in immunocompromized hemophilia A mice transplanted with genetically manipulated human cord blood stem cells. Blood 2014, 123(3):395-403.10.1182/blood-2013-08-520478CrossRefGoogle Scholar
Chen, Y, Luo, X, Chen, J, Schroeder, JA, Baumgartner, KC, Hu, J, and Shi, Q. Immune tolerance developed in platelet-targeted FVIII gene therapy is CD4 T cell-mediated. J Thromb Haemost. 2017 Oct;15(10):1994-2004.10.1111/jth.13800CrossRefGoogle Scholar